Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 1 March 2023 28 February 2024 28 February 2024 14673845 Mr Narinder Kohli Mrs Manjinder Kohli iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14673845 2023-02-28 14673845 2024-02-28 14673845 2023-03-01 2024-02-28 14673845 frs-core:CurrentFinancialInstruments 2024-02-28 14673845 frs-core:Non-currentFinancialInstruments 2024-02-28 14673845 frs-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28 14673845 frs-bus:FilletedAccounts 2023-03-01 2024-02-28 14673845 frs-bus:Micro-entities 2023-03-01 2024-02-28 14673845 frs-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-28 14673845 frs-bus:Director1 2023-03-01 2024-02-28 14673845 frs-bus:CompanySecretary1 2023-03-01 2024-02-28
Registered number: 14673845
Mn Pharma International Limited
Unaudited Financial Statements
For The Year Ended 28 February 2024
Balance Sheet
Registered number: 14673845
2024
£
Fixed assets 120,000
Current assets 196,016
Creditors: Amounts Falling Due Within One Year (92,259 )
NET CURRENT ASSETS 103,757
TOTAL ASSETS LESS CURRENT LIABILITIES 223,757
Creditors: Amounts Falling After More Than One Year (220,000 )
Accruals and deferred income (1,200 )
NET ASSETS 2,557
CAPITAL AND RESERVES 2,557

Notes

1. General Information
Mn Pharma International Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14673845 . The registered office is 925 Finchley Road , London , NW11 7PE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 5
5
Page 0
Page 1
For the year ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Narinder Kohli
Director
27 September 2024